Literature DB >> 26306754

Predicting Collateral Status With Magnetic Resonance Perfusion Parameters: Probabilistic Approach With a Tmax-Derived Prediction Model.

Mi Ji Lee1, Jeong Pyo Son1, Suk Jae Kim1, Sookyung Ryoo1, Sook-Young Woo1, Jihoon Cha1, Gyeong-Moon Kim1, Chin-Sang Chung1, Kwang Ho Lee1, Oh Young Bang2.   

Abstract

BACKGROUND AND
PURPOSE: Good collateral flow is an important predictor for favorable responses to recanalization therapy and successful outcomes after acute ischemic stroke. Magnetic resonance perfusion-weighted imaging (MRP) is widely used in patients with stroke. However, it is unclear whether the perfusion parameters and thresholds would predict collateral status. The present study evaluated the relationship between hypoperfusion severity and collateral status to develop a predictive model for good collaterals using MRP parameters.
METHODS: Patients who were eligible for recanalization therapy that underwent both serial diffusion-weighted imaging and serial MRP were enrolled into the study. A collateral flow map derived from MRP source data was generated through automatic postprocessing. Hypoperfusion severity, presented as proportions of every 2-s Tmax strata to the entire hypoperfusion volume (Tmax≥2 s), was compared between patients with good and poor collaterals. Prediction models for good collaterals were developed with each Tmax strata proportion and cerebral blood volumes.
RESULTS: Among 66 patients, 53 showed good collaterals based on MRP-based collateral grading. Although no difference was noted in delays within 16 s, more severe Tmax delays (Tmax16-18 s, Tmax18-22 s, Tmax22-24 s, and Tmax>24 s) were associated with poor collaterals. The probability equation model using Tmax strata proportion demonstrated high predictive power in a receiver operating characteristic analysis (area under the curve=0.9303; 95% confidence interval, 0.8682-0.9924). The probability score was negatively correlated with the volume of infarct growth (P=0.030).
CONCLUSIONS: Collateral status is associated with more severe Tmax delays than previously defined. The present Tmax severity-weighted model can determine good collaterals and subsequent infarct growth.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  ROC curve; collateral circulation; diffusion magnetic resonance imaging; magnetic resonance imaging; stroke

Mesh:

Year:  2015        PMID: 26306754     DOI: 10.1161/STROKEAHA.115.009828

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Relationships between brain perfusion and early recanalization after intravenous thrombolysis for acute stroke with large vessel occlusion.

Authors:  Pierre Seners; Guillaume Turc; Stéphanie Lion; Jean-Philippe Cottier; Tae-Hee Cho; Caroline Arquizan; Serge Bracard; Canan Ozsancak; Laurence Legrand; Olivier Naggara; Séverine Debiais; Yves Berthezene; Vincent Costalat; Sébastien Richard; Christophe Magni; Norbert Nighoghossian; Ana-Paula Narata; Cyril Dargazanli; Benjamin Gory; Jean-Louis Mas; Catherine Oppenheim; Jean-Claude Baron
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-19       Impact factor: 6.200

2.  A novel method to assess pial collateralization from stroke perfusion MRI: subdividing Tmax into anatomical compartments.

Authors:  Arne Potreck; Fatih Seker; Angelika Hoffmann; Johannes Pfaff; Simon Nagel; Martin Bendszus; Sabine Heiland; Mirko Pham
Journal:  Eur Radiol       Date:  2016-05-24       Impact factor: 5.315

3.  Acute reperfusion without recanalization: Serial assessment of collaterals within 6 h of using perfusion-weighted magnetic resonance imaging.

Authors:  Nikolaos Makris; Leila Chamard; Irene K Mikkelsen; Marc Hermier; Laurent Derex; Salvador Pedraza; Götz Thomalla; Leif Østergaard; Jean-Claude Baron; Norbert Nighoghossian; Yves Berthezène; Tae-Hee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2018-01-02       Impact factor: 6.200

4.  Perfusion profile evaluated by severity-weighted multiple Tmax strata predicts early neurological deterioration in minor stroke with large vessel occlusion.

Authors:  Dong-Seok Gwak; WooChan Choi; Jung-A Kwon; Dong-Hyun Shim; Yong-Won Kim; Yang-Ha Hwang
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-24       Impact factor: 6.960

5.  RAPID CT Perfusion-Based Relative CBF Identifies Good Collateral Status Better Than Hypoperfusion Intensity Ratio, CBV-Index, and Time-to-Maximum in Anterior Circulation Stroke.

Authors:  A Potreck; E Scheidecker; C S Weyland; U Neuberger; C Herweh; M A Möhlenbruch; M Chen; S Nagel; M Bendszus; F Seker
Journal:  AJNR Am J Neuroradiol       Date:  2022-06-09       Impact factor: 4.966

6.  MR Perfusion to Determine the Status of Collaterals in Patients with Acute Ischemic Stroke: A Look Beyond Time Maps.

Authors:  K Nael; A Doshi; R De Leacy; J Puig; M Castellanos; J Bederson; T P Naidich; J Mocco; M Wintermark
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-07       Impact factor: 3.825

Review 7.  Collateral Circulation in Ischemic Stroke: Assessment Tools and Therapeutic Strategies.

Authors:  Oh Young Bang; Mayank Goyal; David S Liebeskind
Journal:  Stroke       Date:  2015-10-08       Impact factor: 7.914

8.  Defining reperfusion post endovascular therapy in ischemic stroke using MR-dynamic contrast enhanced perfusion.

Authors:  Christopher D d'Esterre; Rani Gupta Sah; Zarina Assis; Aron S Talai; Andrew M Demchuk; Michael D Hill; Mayank Goyal; Ting-Yim Lee; Nils D Forkert; Philip A Barber
Journal:  Br J Radiol       Date:  2020-09-17       Impact factor: 3.039

9.  Impact of Slow Blood Filling via Collaterals on Infarct Growth: Comparison of Mismatch and Collateral Status.

Authors:  Jeong Pyo Son; Mi Ji Lee; Suk Jae Kim; Jong-Won Chung; Jihoon Cha; Gyeong-Moon Kim; Chin-Sang Chung; Kwang Ho Lee; Oh Young Bang
Journal:  J Stroke       Date:  2016-12-12       Impact factor: 6.967

10.  The ratio between cerebral blood flow and Tmax predicts the quality of collaterals in acute ischemic stroke.

Authors:  Ivana Galinovic; Elena Kochova; Ahmed Khalil; Kersten Villringer; Sophie K Piper; Jochen B Fiebach
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.